Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 (ABCG2) Antibody

Este producto es parte de ABCG - ATP Binding Cassette Subfamily G
Product Graph
312€ (60 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 (ABCG2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx006789
tested applications
WB, IF/ICC

Description

ABCG2 Antibody is a Rabbit Polyclonal Antibody against ABCG2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Broad Substrate Specificity ATP-Binding Cassette Transporter ABCG2 (ABCG2)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1/500 - 1/2000, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
60 µl
Size 2
120 µl
Size 3
200 µl
Form
Liquid
Tested Applications
WB, IF/ICC
Buffer
PBS, pH 7.3, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9UNQ0
Gene ID
9429
NCBI Accession
NP_004818.2
Alias
ABC15,ABCP BCRP,BCRP1 BMDP,CD338,CDw338
Background
Antibody anti-ABCG2
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

ABCG2, also known as the breast cancer resistance protein (BCRP), is a well-characterized ATP-binding cassette transporter involved in drug efflux and xenobiotic clearance. It is highly expressed in barrier tissues such as the intestine, liver, kidneys, and blood-brain barrier, where it protects cells by exporting a wide range of substrates, including drugs, toxins, and endogenous metabolites. ABCG2 plays a pivotal role in pharmacokinetics, influencing drug absorption, distribution, and elimination. It is also critical in stem cell biology, where it acts as a marker for side population cells due to its role in drug resistance and dye efflux. Overexpression of ABCG2 is a major contributor to multidrug resistance in cancer, as it actively pumps chemotherapeutic agents out of tumor cells, reducing their efficacy. Structurally, ABCG2 is a half-transporter that forms functional homodimers to mediate ATP-driven substrate transport. Dysregulation of ABCG2 has been linked to diseases such as gout and certain cancers, making it a target of interest in oncology and pharmacology.

Related Products

EH1095

Human ABCG2(ATP-binding cassette sub-family G member 2) ELISA Kit

Ver Producto
ER1862

Rat ABCG2(ATP-binding cassette sub-family G member 2) ELISA Kit

Ver Producto
P2000

Recombinant Human ABCG2

Ver Producto